首页> 外文期刊>BMC Nephrology >Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals
【24h】

Perspectives on clinical use of bioimpedance in hemodialysis: focus group interviews with renal care professionals

机译:血液透析中生物阻抗在临床上的应用前景:与肾脏护理专业人员的焦点小组访谈

获取原文
       

摘要

Inadequate volume control may be a main contributor to poor survival and high mortality in hemodialysis patients. Bioimpedance measurement has the potential to improve fluid management, but several dialysis centers lack an agreed fluid management policy, and the method has not yet been implemented. Our aim was to identify renal care professionals’ perceived barriers and facilitators for use of bioimpedance in clinical practice. Qualitative data were collected through four focus group interviews with 24 renal care professionals: dieticians, nephrologists and nurses, recruited voluntarily from a nation-wide selection of hemodialysis centers, having access to a bioimpedance-device. The participants were connected to each other and a moderator via equipment for telemedicine and the sessions were recorded. The interviews were semi-structured, focusing on the participants’ perceptions of use of bioimpedance in clinical practice. Thematic content analysis was performed in consecutive steps, and data were extracted by employing an inductive, interactive, comparative process. Several barriers and facilitators to the use of bioimpedance in clinical practice were identified, and a multilevel approach to examining barriers and incentives for change was found to be applicable to the ideas and categories that arose from the data. The determinants were categorized on five levels, and the different themes of the levels illustrated with quotations from the focus groups participants. Determinants for use of bioimpedance were identified on five levels: 1) the innovation itself, 2) the individual professional, 3) the patient, 4) the social context and 5) the organizational context. Barriers were identified in the areas of credibility, awareness, knowledge, self-efficacy, care processes, organizational structures and regulations. Facilitators were identified in the areas of the innovation’s attractiveness, advantages in practice, and collaboration. Motivation, team processes and organizational capacities appeared as both barriers and facilitators.
机译:音量控制不足可能是导致血液透析患者生存率低和死亡率高的主要原因。生物阻抗测量具有改善液体管理的潜力,但一些透析中心缺乏商定的液体管理政策,该方法尚未实施。我们的目的是确定肾脏护理专业人员在临床实践中使用生物阻抗的公认障碍和促进因素。通过与24位肾脏护理专业人员(营养师,肾病学家和护士)进行的四个焦点小组访谈收集了定性数据,这些专家是从全国范围内选择的血液透析中心自愿招募的,并且可以使用生物阻抗装置。参加者通过远程医疗设备相互连接并担任主持人,并记录了会议情况。访谈是半结构化的,重点是参与者对在临床实践中使用生物阻抗的看法。主题内容分析在连续的步骤中进行,并通过归纳,互动,比较的过程提取数据。确定了在临床实践中使用生物阻抗的几个障碍和促进者,并且发现了一种多层次的方法来检查改变的障碍和诱因,发现该方法适用于从数据中产生的想法和类别。决定因素分为五个级别,不同级别的主题以焦点小组参与者的报价为例。在以下五个级别上确定了使用生物阻抗的决定因素:1)创新本身,2)个人专业人员,3)患者,4)社会背景和5)组织背景。在信誉,意识,知识,自我效能,护理流程,组织结构和法规等领域确定了障碍。在创新的吸引力,实践中的优势和协作方面确定了促进者。动机,团队流程和组织能力似乎是障碍和促进者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号